Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Psychotic symptoms in Parkinson's disease. From description to etiology.
Papapetropoulos S, Mash DC. Papapetropoulos S, et al. J Neurol. 2005 Jul;252(7):753-64. doi: 10.1007/s00415-005-0918-5. J Neurol. 2005. PMID: 15999234 Review.
Psychotic symptoms are common in Parkinson's disease (PD) and occur in at least 20% of medication-treated patients. Benign visual hallucinations usually appear earlier, while malignant hallucinations, confusional states, delusions, paranoid beliefs, agitation, and delirium …
Psychotic symptoms are common in Parkinson's disease (PD) and occur in at least 20% of medication-treated patients. Benign visual hal …
Phenotypic associations of tau and ApoE in Parkinson's disease.
Papapetropoulos S, Farrer MJ, Stone JT, Milkovic NM, Ross OA, Calvo L, McQuorquodale D, Mash DC. Papapetropoulos S, et al. Neurosci Lett. 2007 Mar 6;414(2):141-4. doi: 10.1016/j.neulet.2006.12.008. Epub 2007 Jan 3. Neurosci Lett. 2007. PMID: 17204369
Overlaps in clinical, pathological and molecular features of Parkinson's disease (PD), dementing and motor tauopathies have prompted association studies in search of common genetic risk factors that may predispose or modify this spectrum of disorders. To explore possible p …
Overlaps in clinical, pathological and molecular features of Parkinson's disease (PD), dementing and motor tauopathies have prompted …
Regional alpha-synuclein aggregation, dopaminergic dysregulation, and the development of drug-related visual hallucinations in Parkinson's disease.
Papapetropoulos S. Papapetropoulos S. J Neuropsychiatry Clin Neurosci. 2006 Spring;18(2):149-57. doi: 10.1176/jnp.2006.18.2.149. J Neuropsychiatry Clin Neurosci. 2006. PMID: 16720791 Review.
Visual hallucinations in Parkinson's disease are usually treatment-related and occur in at least 30% of patients. Although their clinical and epidemiological features have been extensively reviewed, their etiopathogenesis remains a matter of debate. Based on the current ev …
Visual hallucinations in Parkinson's disease are usually treatment-related and occur in at least 30% of patients. Although their clin …
The effect of depression on motor function and disease severity of Parkinson's disease.
Papapetropoulos S, Ellul J, Argyriou AA, Chroni E, Lekka NP. Papapetropoulos S, et al. Clin Neurol Neurosurg. 2006 Jul;108(5):465-9. doi: 10.1016/j.clineuro.2005.08.002. Epub 2005 Sep 16. Clin Neurol Neurosurg. 2006. PMID: 16150537
OBJECTIVES: Approximately 40% of patients with Parkinson's disease (PD) experience symptoms of depression. Our aim was to evaluate the effect of depression on disease severity, motor function and other phenotypic characteristics of PD. ...CONCLUSIONS: Depression in PD can …
OBJECTIVES: Approximately 40% of patients with Parkinson's disease (PD) experience symptoms of depression. Our aim was to evaluate th …
Improvement of cervico-trunco-brachial segmental dystonia with topiramate.
Papapetropoulos S, Singer C. Papapetropoulos S, et al. J Neurol. 2006 Apr;253(4):535-6. doi: 10.1007/s00415-005-0029-3. Epub 2005 Nov 22. J Neurol. 2006. PMID: 16328112 No abstract available.
Primary craniocervical dystonia presenting as a respiratory emergency.
Papapetropoulos S, Papapetropoulos N, Singer C. Papapetropoulos S, et al. Among authors: papapetropoulos n. Neurology. 2007 Jan 30;68(5):388-9. doi: 10.1212/01.wnl.0000252893.90894.0b. Neurology. 2007. PMID: 17261689 No abstract available.
An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.
Wider C, Ross OA, Nishioka K, Heckman MG, Vilariño-Güell C, Jasinska-Myga B, Erketin-Taner N, Rademakers R, Graff-Radford NR, Mash DC, Papapetropoulos S, Duara R, Uchikado H, Wszolek ZK, Farrer MJ, Dickson DW. Wider C, et al. Among authors: papapetropoulos s. J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):424-9. doi: 10.1136/jnnp-2011-301413. Epub 2012 Jan 30. J Neurol Neurosurg Psychiatry. 2012. PMID: 22291217 Free PMC article.
PURPOSE: The study investigates the effects of genetic factors on the pathology of Alzheimer's disease (AD) and Lewy body (LB) diseases, including Parkinson's disease and dementia with Lewy bodies. ...
PURPOSE: The study investigates the effects of genetic factors on the pathology of Alzheimer's disease (AD) and Lewy body (LB) diseas …
Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease.
Papapetropoulos S, Lieberman A, Gonzalez J, Singer C, Laufer DZ, Mash DC. Papapetropoulos S, et al. J Neuropsychiatry Clin Neurosci. 2006 Winter;18(1):113-6. doi: 10.1176/jnp.18.1.113. J Neuropsychiatry Clin Neurosci. 2006. PMID: 16525079
Parkinson's disease with dementia (PD-D) and dementia with Lewy bodies (DLB) may result from the same neurodegenerative process with different temporal and spatial courses. ...
Parkinson's disease with dementia (PD-D) and dementia with Lewy bodies (DLB) may result from the same neurodegenerative process with …
Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations.
Papapetropoulos S, McCorquodale DS, Gonzalez J, Jean-Gilles L, Mash DC. Papapetropoulos S, et al. Parkinsonism Relat Disord. 2006 May;12(4):253-6. doi: 10.1016/j.parkreldis.2005.10.005. Epub 2005 Dec 20. Parkinsonism Relat Disord. 2006. PMID: 16368258
Visual hallucinations (VH) are among the most common non-motor complications of Parkinson's disease (PD). A few studies on their etiopathogenesis have suggested involvement of cortical and amygdalar areas. ...
Visual hallucinations (VH) are among the most common non-motor complications of Parkinson's disease (PD). A few studies on their etio …
Lrrk2 and Lewy body disease.
Ross OA, Toft M, Whittle AJ, Johnson JL, Papapetropoulos S, Mash DC, Litvan I, Gordon MF, Wszolek ZK, Farrer MJ, Dickson DW. Ross OA, et al. Among authors: papapetropoulos s. Ann Neurol. 2006 Feb;59(2):388-93. doi: 10.1002/ana.20731. Ann Neurol. 2006. PMID: 16437559
Patients harboring the G2019S substitution usually present with clinical Parkinson's disease. METHODS: Herein, we report that the most common neuropathology of G2019S-associated Parkinson's disease is Lewy body disease. RESULTS: Lrrk2 G2019S was observed in approxim …
Patients harboring the G2019S substitution usually present with clinical Parkinson's disease. METHODS: Herein, we report that the mos …
Feedback